<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898440</url>
  </required_header>
  <id_info>
    <org_study_id>29BRC18.0067</org_study_id>
    <nct_id>NCT03898440</nct_id>
  </id_info>
  <brief_title>Fetal Ano-genital Distance in 2D Ultrasound.</brief_title>
  <acronym>DAG</acronym>
  <official_title>Using Anogenital Distance to Determinate Fetal Gender Beetween 18 et 41 Weeks of Gestation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine a threshold value of fetal anogenital distance in
      2D ultrasound to differentiate male fetuses from female fetuses, starting 18 weeks of
      gestation and until the due date.

      The study also evaluates the feasibility of the measure and its interobserver variability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The anogenital distance of female newborns is shorter than that of male newborns.

      Urogenital disorders, such as hypospadias and micro-penis, are associated with a shorter
      anogenital distance.

      Anogenital distance is a good marker of fetal exposure to androgenic substances.

      Prenatal anogenital distance ultrasound measure can help the diagnosis in case of doubt about
      fetal sexual phenotype or in case of urogenital disorder suspicion (hypospadias or
      micropenis).

      Is the anogenital distance easy to make measure? Can this procedure be reproduced? What are
      the threshold values to determine fetal sex at each term of pregnancy?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">April 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 5, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fetal anogenital distance</measure>
    <time_frame>During fetal ultrasound exam</time_frame>
    <description>The distance will be measured from the center of the anus to the posterior convergence of the fourchette in female fetuses and to the posterior base of the scrotum in male fetuses</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interobserver variability</measure>
    <time_frame>During fetal ultrasound exam</time_frame>
    <description>reproducibility of the anogenital measure: the measure will be taken by two sonographers during the same exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ano-genital distance in mm</measure>
    <time_frame>During fetal ultrasound exam</time_frame>
    <description>the measure is correctly performed and validated by an expert</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated fetal weight</measure>
    <time_frame>During fetal ultrasound exam</time_frame>
    <description>Impact of estimated fetal weight and anogenital distance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal sex determination</measure>
    <time_frame>During fetal ultrasound exam</time_frame>
    <description>concordance of anogenital distance and neonatal sex determination</description>
  </secondary_outcome>
  <enrollment type="Anticipated">318</enrollment>
  <condition>Urogenital Abnormalities</condition>
  <condition>Prenatal Disorder</condition>
  <condition>Sex Development Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All pregnant women follow up at Brest Hospital to 18 weeks of gestation until term, except
        suspicion of fetal pelvic malformations and patients without an exact echographic datation
        of pregnancy between 11 and 13+6 weeks of gestation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant woman

          -  sonographic fetal follow up in Brest Hospital

          -  term&gt;18 weeks of gestation

        Exclusion Criteria:

          -  No datation between 11 weeks of gestation and 13 weeks of gestation and 6 days by
             crown-rump length measurement

          -  Minor

          -  no consent

          -  ultrasound performed by an operator without ultrasonography graduation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Hélène SALIOU</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Brest - Morvan hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Hélène SALIOU</last_name>
    <phone>+33298223333</phone>
    <email>anne-helene.saliou@chu-brest.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>nne-Hélène SALIOU</last_name>
    <phone>+33298223333</phone>
    <email>anne-helene.saliou@chu-brest.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Brest (Morvan)</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Hélène Saliou</last_name>
      <phone>+33298223333</phone>
      <email>anne-helene.saliou@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>July 16, 2019</last_update_submitted>
  <last_update_submitted_qc>July 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anogenital distance</keyword>
  <keyword>prenatal</keyword>
  <keyword>sex determination</keyword>
  <keyword>androgen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urogenital Abnormalities</mesh_term>
    <mesh_term>Disorders of Sex Development</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available after the publication of result and ending three years maximum following the last visit of the last patient</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. requestors will be required to sign and complete a data access agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

